Prodrugs revisited: the "ad hoc" approach as a complement to ligand design.
Testa
B
B
Institut de Chimie thérapeutique, Université de Lausanne, Switzerland.
Caldwell
J
J
D015195:Drug Design; D006801:Humans; D008024:Ligands; D011355:Prodrugs / Q000737:chemistry* / Q000378:metabolism / Q000493:pharmacokinetics / Q000494:pharmacology; D013329:Structure-Activity Relationship
D008024:Ligands; D011355:Prodrugs